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Abstract
Mice are often the model of choice for genomic research because of their high similarity
to the human genome and relatively easy maintenance. Thus, understanding the mechanisms and
principles of their genome is vital to advancing our knowledge about human biology. Long
interspersed elements type 1 (LINE-1s or L1s) are transposable elements within mammalian
DNA. Promoter activities have been identified for the human L1 5’ untranslated region (5’UTR)
in both the sense and antisense orientation, but it was previously unknown if mouse L1 5’UTRs
have antisense promoter activity. The goal of my project was to uncover mouse L1 5’UTR
promoter activity in the antisense orientation. Various mouse L1 5’UTR promoters were
designed in the antisense orientation. The promoter constructs were transfected into NIH/3T3
mouse fibroblast cells, and the promoter activity was quantitatively assessed by a dual-luciferase
assay. The results showed promoter activity in the antisense orientation. Like the human genome,
mouse L1s display both sense and antisense promoter activities revealing a further similarity
between the two species.

Introduction
Long interspersed elements type 1 (LINE-1s or L1s) are abundant retrotransposons that
populate mammalian genomes. The promoter activities of L1 retrotransposons reside in the 5’
untranslated region (5’UTR)1. Specifically, the human genome is known to contain L1 promoter
activity in both the sense and antisense orientations2. The antisense promoter activity affects as
many as 4% of human genes by forming chimeric transcripts with neighboring genes3. However,
the antisense promoter activities of mouse L1 5’UTRs have been previously uncharacterized.
In the mammalian genome, natural antisense promoters have a considerable role in
conventional gene expression. The chimeric transcripts that they regulate are responsible for
cellular processes such as vesicle-mediated transport, protein transport and modification, and
mitotic processes3,4. The transcripts are also known to be involved in methylation of DNA,
histone modification, and RNA modification5. Additional involvement in the genome is
continually being discovered.
The laboratory mouse is an important animal model for studying the biology of L1
retrotransposons due to their high similarity to the human genome, relative ease of maintenance
and high reproductive rates. Understanding mouse L1 promoter activity is critical for
investigating the role of L1 in development and disease. For example, the activation of the L1
promoter sequence in tumor cells potentially increases the occurrence of oncogenic
mutagenesis6. Additionally, an antisense L1 promoter is hypomethylated in tumor-bearing
bladders but not in normal bladders, and its activation drives the expression of a truncated by
constitutively active MET oncogene in bladder epithelium7. L1 promoter activity in the antisense
orientation has also been reported to alter gene structure, activate genes, and silence genes in the

human genome8. The experiment may also lead to the application of L1 promoters in genetic
engineering or gene therapy. Determination of mouse L1 5’UTR antisense activity broadens
understanding of the mechanisms and characteristics of L1 promoters.

Methods and Results
Seven plasmid constructs containing sense oriented L1 promoter were used as the starting
material in the experimental procedure: pLK049, pLK050, pLK051, pLK087, pLK088, pLK089,
and pCH117 (Figure 1). They contain sense-oriented L1 promoters corresponding to mouse L1
A_I, Tf_I, Gf_I, A_II, Tf_II, Tf_III, and human L1 promoter, respectively. The promoter activity
of the respective sense-oriented promoter has been previously measured in our lab by
transfection into mouse NIH/3T3 cells followed by a dual-luciferase assay.
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Figure 1. Dual-luciferase reporter constructs. The L1 promoter is located upstream of and drives the expression
of the firefly luciferase (Fluc) and is variable in each of the seven plasmid constructs. The Fluc activity is indicative
of L1 promoter activity. Similarly, a herpes simplex virus thymidine kinase (HSV-TK) promoter is present upstream
of and drives the expression of Renilla luciferase (Rluc). The Rluc activity is used to normalize transfection
efficiency. An ampicillin resistance gene (AMP) is also present on the plasmid construct.

A forward and a reverse primer were designed for each of the seven plasmids to be
cloned. The reverse complement of the L1 5’UTR promoter region flanked by the two distinct
SfiI sites was obtained from the parental plasmid. The reverse complement sequence was then
inserted between the same two flanking SfiI sites (Figure 2). Primer sequences were derived
from the resulting flanking regions (Table 1). An adenine nucleotide was added to the 5’ end of
the primers. Nucleotide length, % GC content, and melting temperature were recorded for each
primer. Primers were ordered from Eurofins Genomics Company and resuspended in molecular
biology grade water.
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Figure 2. Primers for cloning L1 5’UTR in its antisense orientation. The L1 5’UTR is flanked by two
heterotypic SfiI sites, denoted as SfiI-a and SfiI-b, with recognition sequences shown. The bent arrows show
transcriptional direction. The green arrows show primers used to amplify the 5’UTR. Each has a SfiI site embedded
in its 5’ end but with the opposite SfiI site. Seven pairs of forward and reverse primers were synthesized, and each
pair was specific to each of the seven promoters.

Table 1. Primers designed.
PCR
Template
pLK049
pLK049
pLK050
pLK050
pLK051
pLK051
pLK087
pLK087
pLK088
pLK088
pLK089
pLK089
pCH117
pCH117

Primer
Name
WA1698
WA1699
WA1700
WA1701
WA1702
WA1703
WA1704
WA1705
WA1706
WA1707
WA1708
WA1709
WA1710
WA1711

Primer
Orientation
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse
Forward
Reverse

Primer Sequence
AGGCCTGACAGGCCGTGCCTGCCCCA
AGGCCAAAATGGCCCTGGTAATCTCTGAAGCT
AGGCCTGACAGGCCGACAGCCGGCCA
AGGCCAAAATGGCCCTGGTAATCTCTGGAGTTA
AGGCCTGACAGGCCTGAGAGCACGGGGG
AGGCCAAAATGGCCCTGGCAATCTCTGGAG
AGGCCTGACAGGCCGCGCCTGCCCC
AGGCCAAAATGGCCCTGGTAATCTCTGAAGCT
AGGCCTGACAGGCCGACAGCCGGCCA
AGGCCAAAATGGCCCTGGTAATCTCTGGAGTTA
AGGCCTGACAGGCCGACAGCCGGCCA
AGGCCAAAATGGCCCTGGTAATCTCTGGAGTTA
AGGCCTGACAGGCCGCTCTAGCCCTGG
AGGCCAAAATGGCCCTTTGTGGTTTTATCTACTTTTG

Polymerase chain reaction (PCR) was done to amplify the selected promoter sequence in
the antisense orientation. In a reaction tube 15 µL dH2O, 5 µL 5x GXL buffer, 1.5 µL dNTPs, 1
µL reverse primer, 1 µL forward primer, 0.5 µL PrimeStar GXL DNA polymerase, and 1 µL of
template plasmid were combined. The mixture was created for each plasmid. PCR cycled 30
times at 98 ºC for 10 s, 60 ºC for 15 s, and 68 ºC for 60 s. Gel electrophoresis of the PCR
products was then performed using a 1% agarose gel containing ethidium bromide. The DNA
band of each product was then examined with long-wave UV light (Figure 3), extracted, and
purified using the QIAquick PCR purification kit protocol.

Figure 3. Gel electrophoresis of PCR products using (A) using pLK049 and pCH117 or (B) pLK050, pLK051,
pLK087, pLK088, and pLK089 as templates. A 100 bp ladder was used as the DNA molecular weight standard.
The expected amplicon sizes (bp) are indicated under the gel images. Control: no template control. The results of the
gel electrophoresis confirmed correct fragment lengths, and the experiment continued. The DNA was then extracted
and purified to prepare for the digestion and ligation procedure.

Plasmid pCH117 and the PCR products underwent a digestion procedure using SfiI
restriction enzyme. Two reaction mixtures were created. The first mixture contained 19 µL
dH2O, 3 µL 10x NEB cutsmart buffer, 1 µL SfiI restriction enzyme, 1 µg (6 µL) pCH117, and 1
µL NheI-HF restriction enzyme and was incubated at 37 ºC for 2 hours and then at 50 ºC
overnight. The second mixture contained 26 µL of the purified PCR product, 3 µL of 10x NEB
cutsmart buffer, and 1 µL of SfiI restriction enzyme and was incubated overnight at 50 ºC. The
result from the first reaction was a plasmid backbone without an L1 5’UTR promoter sequence.
The backbone DNA then underwent a ligation reaction where the antisense L1 promoters were
incorporated into the plasmid backbone sequence (Figure 4). In a reaction tube 4 µL dH2O, 1.5
µL 10x T4 DNA ligase buffer, 1 µL backbone DNA, 7.5 µL purified PCR product, and 1 µL T4

ligase were combined. A no-insert control reaction tube was created with 11.5 µL dH2O, 1.5 µL
10x T4 DNA ligase buffer, 1 µL backbone DNA, and 1 µL T4 ligase.
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Figure 4. Restriction digestion and ligation into plasmid backbone. The SfiI digested antisense L1 5’UTR DNA
fragment was ligated to the plasmid backbone containing compatible heterotypic SfiI-a/SfiI-b ends. Figure 3 shows
the sequences of the sticky ends and the complimentary locations of ligation. The result of the ligation was
constructs containing the L1 5’UTR in its antisense orientation relative to Fluc. The antisense plasmid construct
counterparts for pLK049, pLK050, pLK051, pLK087, pLK088, pLK089, and pCH117 were named pJT01, pJT02,
pJT03, pJT04, pJT05, pJT06, and pJT07 respectively.

The ligated plasmids (pJT01-pJT07) then underwent a transformation procedure. Each of
the plasmid constructs was combined with TOP10 E. coli cells. The combination underwent a
heat shock, and prepared LB-carbenicillin plates were inoculated with the bacteria containing the
plasmid inserts. A control plate was inoculated with TOP10 E. coli cells transformed with a
ligation reaction without 5’UTR inserts to evaluate the level of assay background due to selfligation of plasmid backbones. The plates were incubated for 24 hours before being examined
(Figure 5).

Figure 5. Transformation results of ligated plasmids into competent TOP10 E. coli cells. Colony growth is
shown on the inoculated agar plates. The control included ligation product without PCR insert to serve as a negative
control for transformation. Each plasmid contained an ampicillin resistance gene which allowed the bacteria to
survive on the LB-carbenicillin agar plate. Colony growth after transformation confirmed plasmid uptake by the
TOP10 cells.

Colonies from each plate were collected and cultured in liquid medium. The ZymoPURE
plasmid kit was used to extract purified plasmids from the liquid culture. Three separate colonies
for each antisense plasmid construct (pJT01-pJT07) were purified and digested with PvuII. PvuII
was selected due to its sites of digestion relative to the antisense promoter sequences. PvuII cut
the plasmid at a site directly before the SfiI-a site, in between the two SfiI sites, and directly after
the SfiI-b site. A map for each antisense promoter plasmid under the condition of PvuII
restriction enzyme digestion was generated using MacVector software (Figure 6). All colonies
showed the predicted digestion pattern (Figure 7).

Figure 6. Schematic for screening plasmid clones with restriction enzyme PvuII. The predicted plasmid map for
pJT01 using PvuII is displayed as an example. pJT01 was derived from pLK049 but the L1 5’UTR (red arrow) is
now in antisense orientation relative to the firefly luciferase (the long blue arrow). There are four PvuII restriction
sites (at the base pair locations of 291, 709, 6997, and 8352). Each plasmid had a generated model that was used to
predict fragment lengths for a subsequent gel electrophoresis test.

Figure 7. PvuII restriction enzyme digestion of purified plasmids. Three separate colonies for each antisense
plasmid construct (pJT01-pJT07) were purified and digested with PvuII. A 1 Kb ladder was used on either side of
the gel. pCH117 is the parental plasmid for pJT07 and was digested as a control. The fragment lengths corresponded
with the generated MacVector predictions for each plasmid. Two clones for each plasmid were subsequently sent to
Elim Biopharmaceutics Inc for sequencing verification of cloned antisense promoter sequences.

Mouse NIH/3T3 cells (mouse embryonic fibroblast cells) were cultured and maintained
over 3 days until 70% confluency was reached. The plasmids then underwent the transfection
procedure. The plasmids were prepared in a lipid complex and added to 100 µL of cultured cells
at 2x105 cells per mL in a 96-well plate. The plate was incubated for a 48-hour period. After
incubation, the cells underwent dual-luciferase reporter assay protocol. Cell lysis buffer was
added to each well with minimized light exposure followed by 15 minutes of incubation at room
temperature. First, firefly luciferase activity was measured after Luciferase Assay Reagent II
was added to the plate and used as a measure of the antisense promoter activity. Then Renilla
luciferase activity was measured after Stop & Glo Reagent was added to the plate and used as the
experimental control to normalize transfection efficiency. GloMax Multi Detection System

(Promega) was used for readings. The assay measured Renilla Luciferase activity. The results of
the assay were compared to the results of the sense-oriented promoter activity results (Figure 8).

Figure 8. Results of dual-luciferase assays. Each plasmid was transfected into mouse NIH/3T3 cells, and a dualluciferase assay was conducted two days later. Each sense-oriented plasmid (pLK049 to pCH117) was paired with
its antisense clone (pJT01 to pJT07). The orientation of the L1 5’UTR in the plasmid is indicated in parentheses (S:
sense; AS: antisense). Plasmid pCH117 was a positive control; pLK037 was a negative control (not shown), whose
readout was normalized to 1, representing the assay background.

Discussion and Conclusions
Seven antisense promoter constructs were successfully cloned and tested in a dualluciferase reporter assay. The results of the dual-luciferase assay show promoter activity in each
of the seven antisense L1 5’ UTR plasmid constructs. Antisense promoter activity is
comparatively reduced from its sense-oriented counterpart. The antisense partner of the control
human L1 5’UTR plasmid showed one-tenth of its sense counterpart’s activity, which is

consistent with a previous report9. Results of the other plasmids varied slightly but were
consistent in having antisense promoter activity.
Based on the results, it can be concluded that mouse L1 5’UTR display antisense
promoter activity, confirming another shared characteristic between the human and mouse
genomes. The information obtained from this experiment can be used in future genetic research
projects using mice as comparative models. Future studies should focus on characterizing
chimeric transcripts initiated from the antisense L1 promoter and their impact on neighboring
gene expression.
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Addendum
The findings from this project have been incorporated into a bioRxiv preprint
(https://www.biorxiv.org/content/10.1101/2021.12.03.471143v1), for which J.T. is a co-author.
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